Tenax Therapeutics Files 2024 10-K
Ticker: TENX · Form: 10-K · Filed: Mar 25, 2025 · CIK: 34956
| Field | Detail |
|---|---|
| Company | Tenax Therapeutics, INC. (TENX) |
| Form Type | 10-K |
| Filed Date | Mar 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceuticals, annual-report
Related Tickers: TENX
TL;DR
TENX filed its 2024 10-K. Check financials and risks.
AI Summary
Tenax Therapeutics, Inc. filed its 2024 10-K on March 25, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Oxygen Biotherapeutics, Inc., is involved in the pharmaceutical preparations industry. The filing details its business operations, financial condition, and risk factors. Specific financial figures and executive compensation details are not readily available in this header-only extract.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Tenax Therapeutics' performance and strategic direction for the fiscal year 2024. It is crucial for understanding the company's financial health and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Tenax Therapeutics is subject to significant regulatory, clinical trial, and market risks inherent in drug development and commercialization.
Key Numbers
- 2834 — SIC Code (Pharmaceutical Preparations industry classification)
Key Players & Entities
- TENAX THERAPEUTICS, INC. (company) — Filer
- Oxygen Biotherapeutics, Inc. (company) — Former company name
- 2024-12-31 (date) — Fiscal year end
- 2025-03-25 (date) — Filing date
- Chapel Hill, NC (location) — Business address
FAQ
What is Tenax Therapeutics' primary business activity?
Tenax Therapeutics, Inc. is classified under Standard Industrial Classification code 2834, which pertains to Pharmaceutical Preparations.
When did Tenax Therapeutics file its 2024 10-K report?
The 10-K report for the fiscal year ending December 31, 2024, was filed on March 25, 2025.
What were some previous names of Tenax Therapeutics?
The company was formerly known as Oxygen Biotherapeutics, Inc., Synthetic Blood International Inc, and Sinequanon Corp.
Where is Tenax Therapeutics headquartered?
The company's business and mailing address is 101 Glen Lennox Drive, Suite 300, Chapel Hill, NC 27517.
What is the SEC file number for Tenax Therapeutics?
The SEC file number for Tenax Therapeutics, Inc. is 001-34600.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 25, 2025 regarding TENAX THERAPEUTICS, INC. (TENX).